Market Overview:
The global hybrid imaging market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in hybrid imaging devices. The global hybrid imaging market is segmented by type into PET or CT, SPECT or CT, and PET or MRI. The oncology application segment is expected to account for the largest share of the global hybrid imaging market in 2018. This can be attributed to the increasing incidence of cancer and growing demand for advanced diagnostic techniques for its treatment.
Product Definition:
Hybrid Imaging is a term used in radiology to describe the combination of different imaging modalities, usually PET and MRI, to create a more complete and accurate image of the body than either modality could provide on its own. The use of hybrid imaging allows for more precise localization and characterization of lesions than either PET or MRI can provide alone.
PET or CT:
PET or CT is a type of imaging technology that utilizes special detectors to produce images. The technique was first developed for medical diagnosis in the 1960s and has been rapidly evolving since then. PET (Positron Emission Tomography) uses a high-energy beam of electrons, which are captured by the detector to create an image.
SPECT or CT:
Single Photon Emission Computed Tomography (SPECT) or computed tomography (CT) is a diagnostic imaging technique that utilizes light to obtain detailed images of targeted areas. SPECT and CT are two types of hybrid imaging techniques, which use X-rays as the source of ionizing radiation. SPECT uses low energy gamma rays while CT uses high energy X-rays, the major difference being in the source of radiation used to generate image data.
Application Insights:
Oncology accounted for the largest revenue share in 2017 owing to the growing usage of SPECT and CT for cancer detection. The increasing prevalence of cancer is expected to be a major factor driving the segment growth over the forecast period. According to WHO, an estimated 9.6 million people died due to cancer in 2016, which represented 22% of all deaths worldwide.
The cardiology segment is anticipated to witness lucrative growth during the forecast period on account of rising demand for cardiac based studies such as echocardiography and nuclear medicine techniques such as Cardiac PET/CT and Nuclear Medicine (CAT/NMT). Growing awareness about better treatment options leading to improved patient outcomes coupled with technological advancements are some factors that may drive this market during future years.
Regional Analysis:
North America dominated the global hybrid imaging market in 2017. This can be attributed to the presence of major players, high adoption rate of advanced technologies, and well-established healthcare infrastructure. Moreover, increasing demand for diagnostic procedures and rising prevalence of chronic diseases are contributing to regional growth. According to a study published by Oxford University Press in 2018, over 1 million people die due to cancer every year in North America; this accounts for around 6% of total deaths annually across the globe.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the advantages offered by these surgeries over traditional open surgery, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. Hybrid imaging systems are ideally suited for use in minimally invasive procedures as they provide high-resolution images with excellent spatial resolution and low radiation exposure levels.
- Growing demand for image-guided interventions: Image-guided interventions are becoming increasingly popular due to their ability to improve the accuracy of diagnoses and treatment plans while reducing the risk of complications associated with traditional surgical procedures. Hybrid imaging systems offer superior image quality and allow physicians to visualize anatomical structures in great detail, making them an ideal choice for use in image-guided interventions.
- Rising prevalence of chronic diseases: The global prevalence of chronic diseases such as cancer, heart disease, stroke, diabetes mellitus, and respiratory disorders is on the rise due to changing lifestyles and aging populations worldwide. This is leading to an increased demand for diagnostic tests that can help identify these conditions at an early stage so that appropriate treatment can be initiated promptly. Hybrid imaging systems offer several advantages over other diagnostic modalities such as X-rays or CT scans in terms of accuracy and resolution; this is making them a preferred choice among physicians for diagnosing chronic diseases accurately .
Scope Of The Report
Report Attributes
Report Details
Report Title
Hybrid Imaging Market Research Report
By Type
PET or CT, SPECT or CT, PET or MRI
By Application
Oncology, Cardiology, Orthopedics, Others
By Companies
GE Healthcare, Mediso, Philips Healthcare, Siemens Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Hybrid Imaging Market Report Segments:
The global Hybrid Imaging market is segmented on the basis of:
Types
PET or CT, SPECT or CT, PET or MRI
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardiology, Orthopedics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Mediso
- Philips Healthcare
- Siemens Healthcare
Highlights of The Hybrid Imaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PET or CT
- SPECT or CT
- PET or MRI
- By Application:
- Oncology
- Cardiology
- Orthopedics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hybrid Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hybrid imaging is a process that combines two or more different imaging modalities to create an image. This can include using X-ray, MRI, CT scans and other types of medical images.
Some of the major players in the hybrid imaging market are GE Healthcare, Mediso, Philips Healthcare, Siemens Healthcare.
The hybrid imaging market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hybrid Imaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hybrid Imaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hybrid Imaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hybrid Imaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hybrid Imaging Market Size & Forecast, 2018-2028
4.5.1 Hybrid Imaging Market Size and Y-o-Y Growth
4.5.2 Hybrid Imaging Market Absolute $ Opportunity
Chapter 5 Global Hybrid Imaging Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hybrid Imaging Market Size Forecast by Type
5.2.1 PET or CT
5.2.2 SPECT or CT
5.2.3 PET or MRI
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hybrid Imaging Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hybrid Imaging Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Orthopedics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hybrid Imaging Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hybrid Imaging Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hybrid Imaging Analysis and Forecast
9.1 Introduction
9.2 North America Hybrid Imaging Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hybrid Imaging Market Size Forecast by Type
9.6.1 PET or CT
9.6.2 SPECT or CT
9.6.3 PET or MRI
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hybrid Imaging Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Cardiology
9.10.3 Orthopedics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hybrid Imaging Analysis and Forecast
10.1 Introduction
10.2 Europe Hybrid Imaging Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hybrid Imaging Market Size Forecast by Type
10.6.1 PET or CT
10.6.2 SPECT or CT
10.6.3 PET or MRI
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hybrid Imaging Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Cardiology
10.10.3 Orthopedics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hybrid Imaging Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hybrid Imaging Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hybrid Imaging Market Size Forecast by Type
11.6.1 PET or CT
11.6.2 SPECT or CT
11.6.3 PET or MRI
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hybrid Imaging Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Cardiology
11.10.3 Orthopedics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hybrid Imaging Analysis and Forecast
12.1 Introduction
12.2 Latin America Hybrid Imaging Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hybrid Imaging Market Size Forecast by Type
12.6.1 PET or CT
12.6.2 SPECT or CT
12.6.3 PET or MRI
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hybrid Imaging Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Cardiology
12.10.3 Orthopedics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hybrid Imaging Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hybrid Imaging Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hybrid Imaging Market Size Forecast by Type
13.6.1 PET or CT
13.6.2 SPECT or CT
13.6.3 PET or MRI
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hybrid Imaging Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Cardiology
13.10.3 Orthopedics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hybrid Imaging Market: Competitive Dashboard
14.2 Global Hybrid Imaging Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Mediso
14.3.3 Philips Healthcare
14.3.4 Siemens Healthcare
